A randomized phase II study of epigenetic priming with azacitidine and entinostat followed by nivolumab versus nivolumab monotherapy in previously treated metastatic non-small cell lung cancer.-论文-万方医学网

首页> > A randomized phase II study of epigenetic priming with azacitidine and entinostat followed by nivolumab versus nivolumab monotherapy in previously treated metastatic non-small cell lung cancer.

A randomized phase II study of epigenetic priming with azacitidine and entinostat followed by nivolumab versus nivolumab monotherapy in previously treated metastatic non-small cell lung cancer.

导出原文传递

翻译打印收藏纠错

第一作者： Marrone, Kristen A.

作者： Marrone, Kristen A. ^[1] ; Anagnostou, Valsamo ^[2] ; Topper, Michael J. ^[3] ; Smith, Kellie ; Zhang, Jiajia ; Prophet, Elisabeth ; Reimer, Joanne ; Fitzpatrick, Margaret ; Velculescu, Victor ; Forde, Patrick ; Hann, Christine ; Kelly, Ronan ; Ettinger, David ; Zahnow, Cynthia ; Rivera, Jorge ; Gitlitz, Barbara ; Pardoll, Drew ; Baylin, Stephen ; Brahmer, Julie

作者单位： Johns Hopkins Univ,Johns Hopkins Univ, SKCCC, Baltimore, MD USA ^[1] Baylor Univ,Baylor Univ, Sch Med, Houston, TX 77030 USA ^[2] USC Keck Sch Med,USC Keck Sch Med, Los Angeles, CA USA ^[3]

发布时间 2022-06-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

A randomized phase II study of epigenetic priming with azacitidine and entinostat followed by nivolumab versus nivolumab monotherapy in previously treated metastatic non-small cell lung cancer.

相似文献

同项目论文

相关期刊

检索历史 清除

A randomized phase II study of epigenetic priming with azacitidine and entinostat followed by nivolumab versus nivolumab monotherapy in previously treated metastatic non-small cell lung cancer.

相似文献

同项目论文

相关期刊

检索历史清除